William Taverner

William is passionate about the translation of science and innovation for the development of novel cancer therapies. Before joining Theolytics, William completed his PhD studies in Oncolytic Immunotherapy at the University of Oxford. He was a part of the synthetic biology doctoral training programme during his PhD studies, and his research interests focused on the application of synthetic biology approaches to the development of cancer killing viral agents. William also has a BSc and Mbiol in Genetics from the University of Leeds.